Amyloid oligomers: A joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis

PH Nguyen, A Ramamoorthy, BR Sahoo… - Chemical …, 2021 - ACS Publications
Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting
either the central nervous system or a variety of peripheral tissues. Structural and dynamic …

Amyloid formation as a protein phase transition

TCT Michaels, D Qian, A Šarić, M Vendruscolo… - Nature Reviews …, 2023 - nature.com
The formation of amyloid fibrils is a general class of protein self-assembly behaviour, which
is associated with both functional biology and the development of a number of disorders …

Half a century of amyloids: past, present and future

PC Ke, R Zhou, LC Serpell, R Riek… - Chemical Society …, 2020 - pubs.rsc.org
Amyloid diseases are global epidemics with profound health, social and economic
implications and yet remain without a cure. This dire situation calls for research into the …

Impact of nanoparticles on amyloid peptide and protein aggregation: a review with a focus on gold nanoparticles

T John, A Gladytz, C Kubeil, LL Martin, HJ Risselada… - Nanoscale, 2018 - pubs.rsc.org
Society is increasingly exposed to nanoparticles as they are ubiquitous in nature and
introduced as man-made air pollutants and as functional ingredients in cosmetic products as …

Fundamentals of cross-seeding of amyloid proteins: an introduction

B Ren, Y Zhang, M Zhang, Y Liu, D Zhang… - Journal of materials …, 2019 - pubs.rsc.org
Misfolded protein aggregates formed by the same (homologous) or different
(heterologous/cross) sequences are the pathological hallmarks of many protein misfolding …

Graphene quantum dots against human IAPP aggregation and toxicity in vivo

M Wang, Y Sun, X Cao, G Peng, I Javed, A Kakinen… - Nanoscale, 2018 - pubs.rsc.org
The development of biocompatible nanomaterials has become a new frontier in the
detection, treatment and prevention of human amyloid diseases. Here we demonstrated the …

Mitigation of amyloidosis with nanomaterials

PC Ke, EH Pilkington, Y Sun, I Javed… - Advanced …, 2020 - Wiley Online Library
Amyloidosis is a biophysical phenomenon of protein aggregation with biological and
pathogenic implications. Among the various strategies developed to date, nanomaterials …

[HTML][HTML] The role of surfaces on amyloid formation

F Grigolato, P Arosio - Biophysical Chemistry, 2021 - Elsevier
Interfaces can strongly accelerate or inhibit protein aggregation, destabilizing proteins that
are stable in solution or, conversely, stabilizing proteins that are aggregation-prone …

Modulation of amyloid protein fibrillation by synthetic polymers: Recent advances in the context of neurodegenerative diseases

P Ghosh, P De - ACS Applied Bio Materials, 2020 - ACS Publications
Protein misfolding and aggregation have attracted immense research interests due to their
connection with an array of degenerative diseases including neurodegenerative disorders …

Self-therapeutic nanomaterials: Applications in biology and medicine

J Seaberg, JR Clegg, R Bhattacharya, P Mukherjee - Materials Today, 2023 - Elsevier
Over past decades, nanotechnology has contributed to the biomedical field in areas
including detection, diagnosis, and drug delivery via opto-electronic properties or …